Yüklüyor......
Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations
Our aims were to summarize the clinical pharmacokinetics and pharmacodynamics of the dipeptidyl‐peptidase‐4 inhibitor, linagliptin, and to consider how these characteristics influence its clinical utility. Differences between linagliptin and other dipeptidyl‐peptidase‐4 inhibitors were also consider...
Kaydedildi:
| Yayımlandı: | J Diabetes Investig |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217889/ https://ncbi.nlm.nih.gov/pubmed/27180612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12528 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|